Ronald M. Stroshane

884 total citations
22 papers, 608 citations indexed

About

Ronald M. Stroshane is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Ronald M. Stroshane has authored 22 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Molecular Biology and 6 papers in Organic Chemistry. Recurrent topics in Ronald M. Stroshane's work include Microbial Natural Products and Biosynthesis (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Ronald M. Stroshane is often cited by papers focused on Microbial Natural Products and Biosynthesis (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Ronald M. Stroshane collaborates with scholars based in United States and Poland. Ronald M. Stroshane's co-authors include Kenneth L. Rinehart, Richard White, Adorján Aszalós, Kevin M. Byrne, R. R. Brown, Ramesh C. Pandey, Margaret W. Toussaint, D. Perlman, James A. Chan and Peter P. Roller and has published in prestigious journals such as Journal of the American Chemical Society, Antimicrobial Agents and Chemotherapy and Journal of Pharmaceutical Sciences.

In The Last Decade

Ronald M. Stroshane

22 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald M. Stroshane United States 14 232 209 178 59 45 22 608
Atul Khandwala United States 17 97 0.4× 261 1.2× 243 1.4× 51 0.9× 7 0.2× 47 892
J. Castañer Spain 16 164 0.7× 296 1.4× 351 2.0× 49 0.8× 10 0.2× 125 953
A. A. PATCHETT United States 13 72 0.3× 339 1.6× 237 1.3× 141 2.4× 21 0.5× 25 664
Tomoyoshi Hosokawa Japan 14 114 0.5× 318 1.5× 84 0.5× 7 0.1× 44 1.0× 33 629
William H. Koster United States 14 182 0.8× 178 0.9× 300 1.7× 156 2.6× 11 0.2× 25 697
M. Schach von Wittenau United States 17 191 0.8× 250 1.2× 207 1.2× 10 0.2× 28 0.6× 37 743
Renée Aspiotis Canada 10 145 0.6× 371 1.8× 152 0.9× 32 0.5× 5 0.1× 14 808
Barbara Malewicz United States 17 54 0.2× 456 2.2× 66 0.4× 13 0.2× 16 0.4× 29 789
J Poisson France 18 77 0.3× 364 1.7× 360 2.0× 16 0.3× 31 0.7× 96 1.0k

Countries citing papers authored by Ronald M. Stroshane

Since Specialization
Citations

This map shows the geographic impact of Ronald M. Stroshane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald M. Stroshane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald M. Stroshane more than expected).

Fields of papers citing papers by Ronald M. Stroshane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald M. Stroshane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald M. Stroshane. The network helps show where Ronald M. Stroshane may publish in the future.

Co-authorship network of co-authors of Ronald M. Stroshane

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald M. Stroshane. A scholar is included among the top collaborators of Ronald M. Stroshane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald M. Stroshane. Ronald M. Stroshane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graves, Scott S., et al.. (2000). Therapeutic monitoring of sirolimus in human whole-blood samples by high-performance liquid chromatography. Clinical Therapeutics. 22. B25–B37. 35 indexed citations
2.
Stroshane, Ronald M., et al.. (1990). Preliminary study of the pharmacokinetics of oral amifloxacin in elderly subjects. Antimicrobial Agents and Chemotherapy. 34(5). 751–754. 4 indexed citations
3.
Miller, Donald R., Justus J. Fiechtner, James R. Carpenter, et al.. (1987). Plasma hydroxychloroquine concentrations and efficacy in rheumatoid arthritis. Arthritis & Rheumatism. 30(5). 567–571. 32 indexed citations
4.
Hamilton, Robert A., Steven F. Kowalsky, E. M. Wright, et al.. (1986). Effect of the acetylator phenotype on amrinone pharmacokinetics. Clinical Pharmacology & Therapeutics. 40(6). 615–619. 14 indexed citations
5.
Edelson, Jerome, Ronald M. Stroshane, Robert Cody, et al.. (1986). Pharmacokinetics of the bipyridines amrinone and milrinone.. PubMed. 73(3 Pt 2). III145–52. 36 indexed citations
6.
Brown, R. R., Ronald M. Stroshane, & David P. Benziger. (1986). High-performance liquid chromatographic assay for hydroxychloroquine and three of its major metabolites, desethylhydroxychloroquine, desethylchloroquine and bidesethylchloroquine, in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 377. 454–459. 18 indexed citations
7.
Alousi, Adawia A., et al.. (1985). Milrinone. Cardiovascular Drug Reviews. 3(1). 245–283. 2 indexed citations
8.
Brown, R. R., Ronald M. Stroshane, & David P. Benziger. (1985). High-performance liquid chromatographic assay for trilostane and its major metabolite, 17-ketotrilostane, in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 339(2). 440–444. 3 indexed citations
9.
Stroshane, Ronald M., et al.. (1984). Oral and Intravenous Pharmacokinetics of Milrinone in Human Volunteers. Journal of Pharmaceutical Sciences. 73(10). 1438–1441. 51 indexed citations
10.
Chan, James A., Peter P. Roller, Ulrich Weiß, et al.. (1982). Detection of gilvocarcin antitumor complex by a biochemical induction assay (BIA).. The Journal of Antibiotics. 35(4). 529–532. 27 indexed citations
11.
Munro, Murray H. G., Ronald M. Stroshane, & Kenneth L. Rinehart. (1982). Location of guanidino and ureido groups in bluensomycin from 13C NMR spectra of streptomycin and related compounds.. The Journal of Antibiotics. 35(10). 1331–1337. 12 indexed citations
12.
Pandey, Ramesh C., Margaret W. Toussaint, Ronald M. Stroshane, et al.. (1981). Fredericamycin A a new antitumor antibiotic. I. Production, isolation and physicochemical properties.. The Journal of Antibiotics. 34(11). 1389–1401. 97 indexed citations
13.
McGuire, Jeffrey C., et al.. (1980). Biosynthesis of daunorubicin glycosides: role of epsilon-rhodomycinone. Antimicrobial Agents and Chemotherapy. 18(3). 454–464. 24 indexed citations
14.
Chan, James A., et al.. (1979). A Rapid Quantitative Assay of Sparsomycin by High Pressure Liquid Chromatography. Journal of Liquid Chromatography. 2(1). 85–90. 2 indexed citations
15.
Stroshane, Ronald M., et al.. (1979). Isolation and structure elucidation of a novel griseorhodin.. The Journal of Antibiotics. 32(3). 197–204. 35 indexed citations
16.
Stroshane, Ronald M. & D. Perlman. (1977). Fermentation of glucose by Acetobacter melanogenus. Biotechnology and Bioengineering. 19(4). 459–465. 19 indexed citations
17.
Stroshane, Ronald M., et al.. (1976). Spectinomycin biosynthesis studied by carbon magnetic resonance spectroscopy. Journal of the American Chemical Society. 98(10). 3025–3027. 13 indexed citations
18.
Rinehart, Kenneth L. & Ronald M. Stroshane. (1976). Biosynthesis of aminocyclitol antibiotics.. The Journal of Antibiotics. 29(4). 319–353. 79 indexed citations
19.
Rinehart, Kenneth L., et al.. (1974). Carbon-13 as a biosynthetic tool. IV. Biosynthetic incorporation of glucosamine-1-13C and glucose-6-13C into neomycin. Journal of the American Chemical Society. 96(7). 2263–2265. 44 indexed citations
20.
Day, L. E., et al.. (1973). Biosynthesis of Monensin. Antimicrobial Agents and Chemotherapy. 4(4). 410–414. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atul Khandwala Breakdown of academic impact, for papers by J. Castañer Breakdown of academic impact, for papers by A. A. PATCHETT Breakdown of academic impact, for papers by Tomoyoshi Hosokawa Breakdown of academic impact, for papers by William H. Koster Breakdown of academic impact, for papers by M. Schach von Wittenau Breakdown of academic impact, for papers by Renée Aspiotis Breakdown of academic impact, for papers by Barbara Malewicz Breakdown of academic impact, for papers by J Poisson
Rankless by CCL
2026